|
HPC Biosciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
409.85 Cr.
|
P/BV
|
12.48
|
Book Value (Rs.)
|
2.06
|
|
52 Week High/Low (Rs.)
|
26/26
|
FV/ML
|
1/3000
|
P/E(X)
|
350.82
|
|
Bookclosure
|
24/09/2023
|
EPS (Rs.)
|
0.07
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1.19 | 0.36 | 0.58 | 0.23 | 0.57 |
| | | | | | |
| Net CashFlow From Operating Activities | 1.36 | 0.82 | 1.17 | 0.08 | 1.09 |
| Net Cash Used In Investing Activities | 0.06 | -0.79 | -0.96 | -0.10 | -1.87 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.42 | 0.03 | 0.21 | -0.02 | -0.77 |
| Cash And Cash Equivalents Begin of Year | 0.30 | 0.27 | 0.05 | 0.07 | 0.85 |
| Cash And Cash Equivalents End Of Year | 1.72 | 0.30 | 0.27 | 0.05 | 0.07 |
